AVXS-101 (onasemnogene abeparvovec) for SMA1: comparative study with a prospective natural history cohort - Al-Zaidy, SA; Kolb, SJ; Lowes, L; Alfano, LN; Shell, R; Church, KR (J Neuromuscul Dis, 2019)